The results of cardiac retransplantation: an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry
- PMID: 10972218
- DOI: 10.1097/00007890-200008270-00013
The results of cardiac retransplantation: an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry
Abstract
Background: It is well established that repeat heart transplantation has a significantly worse outcome when compared with primary (first time) transplantation. Defining the risk factors for mortality within this group has been difficult due to small numbers of patients at individual centers.
Methods: All cardiac retransplants performed in the United States and registered in the Joint International Society for Heart and Lung Transplantation (ISHLT)/United Network for Organ Sharing (UNOS) Thoracic Registry were analyzed for demographics, morbidity posttransplantation, immunosuppression, and risk factors for mortality.
Results: The study cohort included 514 patients of which 81% were male with a mean age of 47+/-12 years. Time from primary transplant to retransplantation ranged from 1 day to 15.5 years and more than 50% of the patients underwent retransplantation for chronic rejection. More than 60% of patients were in the intensive care unit at the time of retransplantation and more than 40% of the patients were reported to be on some form of life support (ventricular assist device, ventilator, and/or inotropic therapy). Survival for the entire retransplant cohort was 65, 59, and 55% for 1, 2, and 3 years, respectively, but was substantially lower when the intertransplant interval was short. Conversely, when the interval between primary and retransplantation was more than 2 years, 1 year survival postretransplantation approached that of primary transplantation. Additional independent risk factors for mortality for the retransplant cohort included overall cardiac transplant center volume, the use of a ventricular assist device or ventilator, the patient being in the intensive care unit, and recipient age. The four most common causes of death were infection, primary/nonspecific graft failure, chronic rejection (allograft vasculopathy), and acute rejection.
Conclusions: The data confirm that repeat heart transplantation is a higher risk procedure than primary transplantation, especially early after the primary heart transplant.
Similar articles
-
Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry.J Heart Lung Transplant. 1998 Apr;17(4):374-82. J Heart Lung Transplant. 1998. PMID: 9588582
-
Mortality and morbidity after retransplantation after primary heart transplant in childhood: an analysis from the registry of the International Society for Heart and Lung Transplantation.J Heart Lung Transplant. 2014 Mar;33(3):241-51. doi: 10.1016/j.healun.2013.11.006. Epub 2013 Nov 28. J Heart Lung Transplant. 2014. PMID: 24462559
-
Cardiac retransplantation: is it justified in times of critical donor organ shortage? Long-term single-center experience.Eur J Cardiothorac Surg. 2008 Dec;34(6):1185-90. doi: 10.1016/j.ejcts.2008.06.044. Epub 2008 Aug 9. Eur J Cardiothorac Surg. 2008. PMID: 18693029
-
Cardiac retransplantation in children.Ann Thorac Surg. 2004 Aug;78(2):644-9; discussion 644-9. doi: 10.1016/j.athoracsur.2004.02.090. Ann Thorac Surg. 2004. PMID: 15276538 Review.
-
Heart retransplantation.Am J Transplant. 2007 Sep;7(9):2075-81. doi: 10.1111/j.1600-6143.2007.01902.x. Epub 2007 Jul 19. Am J Transplant. 2007. PMID: 17640316 Review.
Cited by
-
Heart Retransplant Recipients Have Better Survival With Concurrent Kidney Transplant Than With Heart Retransplant Alone.J Am Heart Assoc. 2015 Dec 11;4(12):e002435. doi: 10.1161/JAHA.115.002435. J Am Heart Assoc. 2015. PMID: 26656863 Free PMC article.
-
Outcomes and survival following heart retransplantation for cardiac allograft failure: a systematic review and meta-analysis.Ann Cardiothorac Surg. 2018 Jan;7(1):12-18. doi: 10.21037/acs.2018.01.09. Ann Cardiothorac Surg. 2018. PMID: 29492380 Free PMC article. Review.
-
Cardiac Surgery After Heart Transplantation: Elective Operation or Last Exit Strategy?Transplant Direct. 2017 Sep 9;3(10):e209. doi: 10.1097/TXD.0000000000000725. eCollection 2017 Oct. Transplant Direct. 2017. PMID: 29138760 Free PMC article.
-
Chemokines and transplant vasculopathy.Circ Res. 2008 Aug 29;103(5):454-66. doi: 10.1161/CIRCRESAHA.108.182865. Circ Res. 2008. PMID: 18757833 Free PMC article. Review.
-
Heart Retransplantation: Candidacy, Outcomes, and Management.Curr Transplant Rep. 2020;7(1):12-17. doi: 10.1007/s40472-019-00257-y. Epub 2019 Dec 17. Curr Transplant Rep. 2020. PMID: 32435573 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical